For: | Liang WT, Liu XF, Huang HB, Gao ZM, Li K. Prognostic significance of KIF23 expression in gastric cancer. World J Gastrointest Oncol 2020; 12(10): 1104-1118 [PMID: 33133380 DOI: 10.4251/wjgo.v12.i10.1104] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v12/i10/1104.htm |
Number | Citing Articles |
1 |
Dong Xie, Xiaoxiao Chen, Hongxuan Wu, Danmei Ning, Xianwei Cao, Chuan Wan. Prediction of Diagnostic Gene Biomarkers Associated with Immune Infiltration for Basal Cell Carcinoma. Clinical, Cosmetic and Investigational Dermatology 2022; : 2657 doi: 10.2147/CCID.S390770
|
2 |
Zhi Li, Hai-Yan Yang, Xiao-Lan Zhang, Xu Zhang, Yu-Zhou Huang, Xin-Yuan Dai, Liang Shi, Guo-Ren Zhou, Ji-Fu Wei, Qiang Ding. Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt/β-catenin pathway. Journal of Experimental & Clinical Cancer Research 2022; 41(1) doi: 10.1186/s13046-022-02373-7
|
3 |
Rui Song, Juntao Huang, Chenglei Yang, Yuankuan Li, Guohua Zhan, Bangde Xiang. ESPL1 is Elevated in Hepatocellular Carcinoma and Predicts Prognosis. International Journal of General Medicine 2022; : 8381 doi: 10.2147/IJGM.S381188
|
4 |
Xiaoyan Liu, Xiaoqing Xie, Qiulian Li, Xiaohong Xie, Min Xiong, Wenling Han, Wei Xie. KIF23 promotes cervical cancer progression via inhibiting NLRP3‐mediated pyroptosis. The FASEB Journal 2024; 38(10) doi: 10.1096/fj.202400281R
|
5 |
Xin He, Juan Wang, Ru Zhou, Shanshan Yu, Jue Jiang, Qi Zhou. Kinesin family member 23 exerts a protumor function in breast cancer via stimulation of the Wnt/β-catenin pathway. Toxicology and Applied Pharmacology 2022; 435: 115834 doi: 10.1016/j.taap.2021.115834
|
6 |
Jinglin Mi, Shanshan Ma, Wei Chen, Min Kang, Meng Xu, Chang Liu, Bo Li, Fang Wu, Fengju Liu, Yong Zhang, Rensheng Wang, Li Jiang. Integrative Pan-Cancer Analysis of KIF15 Reveals Its Diagnosis and Prognosis Value in Nasopharyngeal Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.772816
|
7 |
Wenting Tang, Li Zhang, Jing Li, Yu Guan. KCNQ1OT1 promotes retinoblastoma progression by targeting miR-339-3p that suppresses KIF23. International Ophthalmology 2023; 43(7): 2419 doi: 10.1007/s10792-023-02641-1
|
8 |
Hongbo Xu, Jingjing Liu, Yajun Zhang, Yan Zhou, Lei Zhang, Jia Kang, Can Ning, Zelai He, Shilong Song. KIF23, under regulation by androgen receptor, contributes to nasopharyngeal carcinoma deterioration by activating the Wnt/β-catenin signaling pathway. Functional & Integrative Genomics 2023; 23(2) doi: 10.1007/s10142-023-01044-w
|
9 |
Yue Ma, Yao Zhang, Xizi Jiang, Jingqian Guan, Huanxi Wang, Jiameng Zhang, Yue Tong, Xueshan Qiu, Renyi Zhou. KIFC3 promotes the proliferation, migration and invasion of non-small cell lung cancer through the PI3K/AKT signaling pathway. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-71602-0
|
10 |
Lipi Akter, Md Abul Hashem, Mohammad Enamul Hoque Kayesh, Md Arju Hossain, Fumie Maetani, Rupaly Akhter, Kazi Anowar Hossain, Md Haroon Or Rashid, Hiroko Sakurai, Takayuki Asai, M. Nazmul Hoque, Kyoko Tsukiyama-Kohara. A preliminary study of gene expression changes in Koalas Infected with Koala Retrovirus (KoRV) and identification of potential biomarkers for KoRV pathogenesis. BMC Veterinary Research 2024; 20(1) doi: 10.1186/s12917-024-04357-5
|
11 |
Xiaojie Bai, Yuanfei Cao, Xin Yan, Kurerban Tuoheti, Guowei Du, Zhao Chen, Huahui Wu, Linfa Guo, Tongzu Liu. Systematic Pan-Cancer Analysis of KIF23 and a Prediction Model Based on KIF23 in Clear Cell Renal Cell Carcinoma (ccRCC). Pharmacogenomics and Personalized Medicine 2021; : 1717 doi: 10.2147/PGPM.S337695
|
12 |
Xiaoqing Liu, Yuanyuan Tian, Ao Yang, Chuang Zhang, Xiaoqing Miao, Wenchao Yang. Antitumor Effects of Poplar Propolis on DLBCL SU-DHL-2 Cells. Foods 2023; 12(2): 283 doi: 10.3390/foods12020283
|
13 |
Qiangqiang Zhong, Wenbo Hong, Lina Xiong. KIF3C: an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer. Aging 2024; doi: 10.18632/aging.205694
|
14 |
Albeiro Marrugo-Padilla, Johana Márquez-Lázaro, Antistio Álviz-Amador. Identification of prognostic biomarkers of invasive ductal carcinoma by an integrated bioinformatics approach. F1000Research 2023; 11: 1075 doi: 10.12688/f1000research.123714.2
|
15 |
Zheng Zhao, Zheng Wang, Zhao-Shi Bao, Wei-Zhen Gao, Yuan-Da Zhang, Ci-Jie Ruan, Tao Lv, Yong Wang, Li-Hua Sun. Mutation and Copy Number Alterations Analysis of KIF23 in Glioma. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.646929
|
16 |
Yuqi Gong, Lingna Zhou, Liya Ding, Jing Zhao, Zhe Wang, Guoping Ren, Jing Zhang, Zhengrong Mao, Ren Zhou. KIF23 is a potential biomarker of diffuse large B cell lymphoma. Medicine 2022; 101(24): e29312 doi: 10.1097/MD.0000000000029312
|
17 |
Tao Wang, Xiaotong Peng, Wenwen Liu, Mei Ji, Jing Sun. Identification and validation of KIF23 as a hypoxia-regulated lactate metabolism-related oncogene in uterine corpus endometrial carcinoma. Life Sciences 2024; 341: 122490 doi: 10.1016/j.lfs.2024.122490
|
18 |
Yu Mu, Haoxiang Liu, Anni Luo, Qingxiang Zhang. KIFC3 promotes the progression of non–small cell lung cancer cells through the PI3K/Akt pathway. Thoracic Cancer 2024; 15(33): 2356 doi: 10.1111/1759-7714.15465
|
19 |
Wenyi Zhang, Ting Chen, Jun Liu, Shali Yu, Lei Liu, Miaosen Zheng, Yifei Liu, Hongbing Zhang, Tingting Bian, Xinyuan Zhao. RAB11FIP1: An Indicator for Tumor Immune Microenvironment and Prognosis of Lung Adenocarcinoma from a Comprehensive Analysis of Bioinformatics. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.757169
|
20 |
Maoshu Bai, Xin Liu. Diagnostic biomarker KIF23 is associated with immune infiltration and immunotherapy response in gastric cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1191009
|